A consultant pharmacist is performing a monthly Medication Regimen Review (MRR) for an 82-year-old resident of a long-term care facility.
The resident has a history of falls, and their regimen includes an antipsychotic prescribed PRN for agitation.
According to CMS guidelines, which of the following is a critical component the pharmacist must address regarding this PRN psychotropic medication?